Skip to main content
NIPH logo

Latest from infectious diseases

151 hits
  1. Covid-19 and impact on mental health: a longitudinal, multi-national study (C-Me).

    Covid-19 and impact on mental health: a longitudinal, multi-national study (C-Me).

    Updated

    The research project C-Me will use data from the Norwegian Mother, Father and Child cohort (MoBa) to answer key questions regarding the mental health impact of Covid-19 in the adolescent and adult population.
    Project
  2. Emergency preparedness register for COVID-19 (Beredt C19)

    Emergency preparedness register for COVID-19 (Beredt C19)

    Updated

    The register (Beredt C19) was established to give the NIPH an ongoing overview and knowledge of the prevalence, causal relationships and consequences of the COVID-19 pandemic in Norway.
    Article
  3. COVID-19 and pregnancy (CoronaPreg)

    COVID-19 and pregnancy (CoronaPreg)

    Updated

    This project will use the Norwegian health registries to understand the consequences of COVID-19 in pregnant women.
    Project
  4. UNITED4Surveillance (EU4Health Joint Action)

    UNITED4Surveillance (EU4Health Joint Action)

    Updated

    The general objective of the project is to strengthen infectious disease surveillance systems at the national level, with improvement of integration, interoperability, and digitalization of data sources.
    Project
  5. Countries with high tuberculosis incidence

    Countries with high tuberculosis incidence

    Updated

    The list of countries with a high incidence of tuberculosis has been moved to The Norwegian Directorate of Health's website. People from these countries are required to undergo tests for tuberculosis.
    Article
    verdenskart
  6. SeroSelectTB

    SeroSelectTB

    Updated

    SeroSelectTB is a multinational project coordinated by the Norwegian Institute of Public Health.
    Project
    SeroSelectTB logo with financing logos.png
  7. Publications from MoBa-Corona, NorFlu-Corona, The Senior Cohort and Young Adult Cohort

    Publications from MoBa-Corona, NorFlu-Corona, The Senior Cohort and Young Adult Cohort

    Updated

    Here is an overview of publications and reports from MoBa-Corona, NorFlu-Corona, The Senior Cohort and Young Adult Cohort.
    Article
    person som leser bok
  8. NorFlu and COVID-19

    NorFlu and COVID-19

    Updated

    When the SARS-CoV-2 pandemic reached Norway in February 2020, there was an immediate need for knowledge on the spread of the virus in the population.
    Article
    nyhetsbrev-norflu-2020.png
  9. About the Corona Household Study

    About the Corona Household Study

    Updated

    The Corona Household Study is a study that investigate the risk of infection, and immunity to, the novel coronavirus (SARS-CoV-2) among people living in the same household. The Data collection phase is completed.
    Article
  10. Norway is among the first countries in the world to have achieved the global treatment target among people diagnosed with hepatitis C

    Norway is among the first countries in the world to have achieved the global treatment target among people diagnosed with hepatitis C

    Updated

    Over 80% of people diagnosed with an active hepatitis C infection have received treatment for their infection. This is the main finding from a new study by the Norwegian Institute of Public Health (NIPH), published in the journal Eurosurveillance.
    Research findings
  11. About the mpox vaccine

    About the mpox vaccine

    Updated

    In this article you can read about who is recommended to take the mpox vaccine, how and where you will be offered the vaccine and about the vaccine’s effect and side effects.
    Article
  12. Using MoBa to understand the COVID-19 pandemic

    Using MoBa to understand the COVID-19 pandemic

    Updated

    This project will follow the spread of COVID-19 disease in Norway over the next few years, and investigate why someone becomes infected and possibly seriously ill.
    Project
  13. Influenza Virological and Epidemiological 2023-2024 season report

    Influenza Virological and Epidemiological 2023-2024 season report

    Updated

    Overall, the 2023-2024 influenza season was of low-to-moderate magnitude, had a protracted course, with influenza A(H1N1) dominating also this season, but cocirculating with A(H3N2) viruses and with much less influenza B/Victoria-lineage viruses.
    Report
    forside_influensarapport 2024.png
  14. Influenza and coronavirus vaccines for pregnant women

    Influenza and coronavirus vaccines for pregnant women

    Updated

    Information about coronavirus and influenza vaccination during pregnancy.
    Information note
    skjermdump infoskriv til gravide om korona- og influensavaksine
  15. Influenza vaccine

    Influenza vaccine

    Updated

    Information note about vaccine against seasonal influenza. The publication contains information about risk groups and health benefits of influenza vaccination.
    Information note
    skjermdump infoskriv influensavaksine risikogrupper
  16. Brief guide to influenza and coronavirus vaccines

    Brief guide to influenza and coronavirus vaccines

    Updated

    Brief information from the Norwegian Institute of Public Health about vaccines against influenza and coronavirus in several languages.
    Information note
    Skjermdump infoskriv kortversjon influensa- og koronavaksine
  17. Dear colleague/Do you work in the health service?

    Dear colleague/Do you work in the health service?

    Updated

    Two different versions of a poster for health care workers.
    Poster
    Skjermdump av engelsk versjon av plakat om influensavaksine, rettet mot helsepersonell
  18. Pregnant? Poster for vaccines against  influenza and coronavirus

    Pregnant? Poster for vaccines against  influenza and coronavirus

    Updated

    Pregnant women and infants have a higher risk of a severe disease course form coronavirus and influenza. Talk to your doctor about vaccines against influenza and coronavirus.
    Poster
    Skjermdump av plakat til gravide om influensa- og koronavaksine
  19. Influenza Virological and Epidemiological season report prepared for the WHO Consultation on the Composition of Influenza Virus Vaccines for the Southern Hemisphere 2025

    Influenza Virological and Epidemiological season report prepared for the WHO Consultation on the Composition of Influenza Virus Vaccines for the Southern Hemisphere 2025

    Updated

    During the 2023-24 season, both A(H1N1) 5a.2a and 5a.2a1 viruses circulated, with a slightly higher prevalence of the 5a.2a1 during the winter outbreak. The A(H3N2) viruses have been mainly from the 2a.3a.1 clade, with J.1 during the winter and J.2 the latest months.
    Report
    Influenza report for 2024
  20. Talk to your doctor about vaccination. Poster for vaccines for adults

    Talk to your doctor about vaccination. Poster for vaccines for adults

    Updated

    Poster
    Skjermdump av plakat om vaksiner til voksne
  21. Vaccine against coronavirus

    Vaccine against coronavirus

    Updated

    Information letter containing information about risk groups and the health benefits of coronavirus vaccination.
    Information note
    skjermdump av koronavaksine
  22. Vaccine recommendations for influenza season 2024-2025

    Vaccine recommendations for influenza season 2024-2025

    Updated

    Almost 1.6 million people in Norway belong to groups with an increased risk of complications from influenza. They are recommended to take the seasonal influenza vaccine.
    Article
    Illustrasjon av mann og dame på benk
  23. Influenza vaccine for children

    Influenza vaccine for children

    Updated

    Most children and young adolescents can tolerate influenza (the ‘flu), but some can become seriously ill. Children and young people in risk groups often have a severe disease course and are therefore recommended to receive the influenza vaccine.
    Article
    Tegning av barn på sofa
  24. Influenza vaccine for pregnant women

    Influenza vaccine for pregnant women

    Updated

    Pregnant women are at increased risk of a severe influenza disease course. Pregnant women in their 2nd and 3rd trimesters should take the influenza vaccine. Women in the 1st trimester with other additional risk factors are also recommended to take the vaccine.
    Article
    Tegning av gravid dame
  25. Influenza vaccine for risk groups

    Influenza vaccine for risk groups

    Updated

    Anyone can become seriously ill from influenza, but certain risk groups are more susceptible to a severe disease course than others. The health benefits can be considerable if people in these risk groups are vaccinated.
    Article
    Tegning av en eldre mann